CYCS, cytochrome c, somatic, 54205

N. diseases: 67; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011644
Disease: Scleroderma
Scleroderma
0.030 Biomarker disease BEFREE Patients enrolled in the Scleroderma Lung Study II (cyclophosphamide [CYC] versus mycophenolate mofetil [MMF]) were included. 31233287 2019
CUI: C0011644
Disease: Scleroderma
Scleroderma
0.030 Biomarker disease BEFREE A retrospective cohort of SSc subjects with ILD, disease duration below seven years and no exposure to CYC or MMF prior to the baseline visit was constructed from the Canadian Scleroderma Research Group registry. 31535689 2019
CUI: C0011644
Disease: Scleroderma
Scleroderma
0.030 Biomarker disease BEFREE RTX is a safe and effective alternative to CYC in the primary therapy of skin and lung manifestations of scleroderma. 30053212 2018